Farley Chele Chiavacci
Known title: DirectorCIK: 0001908750
Associated companies
Transaction History
| CDT | ▲ Buy | Grant | 10,553 | $11K | 2/19/2026 | View on chart |
| CDT | ▲ Buy | Grant | 35,000 | $0 | 8/12/2025 | View on chart |
| CDT | ▲ Buy | Grant | 32,022 | $28K | 3/30/2025 | View on chart |
| CDT | ▲ Buy | Grant | 299,238 | $27K | 11/18/2024 | View on chart |
| CDT | ▲ Buy | Grant | 37,272 | — | 6/11/2024 | View on chart |
| CDT | ▲ Buy | Grant | 15,000 | — | 9/22/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
CDT Highlights Sarborg Quantum Computing IP for Drug Discovery
CDT announced that it is focusing on Sarborg's expanding quantum computing intellectual property and its application to drug discovery. The company was also mentioned among health‑care stocks that moved in Friday's session, showing recent market attention. The stock is currently near a long‑standing support level, which may be observed as the company pursues these initiatives.
CDT Highlights Sarborg Quantum Computing IP for Drug Discovery. CDT announced that it is focusing on Sarborg's expanding quantum computing intellectual property and its application to drug discovery. The company was also mentioned among health‑care stocks that moved in Friday's session, showing recent market attention. The stock is currently near a long‑standing support level, which may be observed as the company pursues these initiatives.